Strengthening dialogue with Asian regulatory agencies will facilitate the access of the Brazilian population to safe and effective medicines and medical devices.
By Ascom/ANVISA
December 06, 2018
Anvisa (the Food and Drug Agency from Brazil) participated past week, from December 3 to 7, of meetings with the regulatory agencies of Japan and South Korea. The major purpose of the meetings, which took place in Tokyo, was to strengthen the regulatory dialogue with the agencies of the two Asian countries and consolidate future partnerships.
The mission of the Agency works to advance the coordination of activities that favor the access of the Brazilian population to safe and effective medicines and medical devices. Nonetheless, promoting the quality of national regulation should contribute to the export of Brazilian products and the attraction of foreign investments in Brazil.
The extensive schedule of appointments for the week featured exclusive meetings of governments and private sectors of medicines and medical devices, as well as a bilateral meeting between Anvisa and the Japanese agencies responsible for risk assessment and the establishment of maximum pesticide residue limits in food.
The mission was conducted by Anvisa’s Director of Registry and Authorizations, Alessandra Bastos Soares, and was attended by the deputy director-president, Patricia Lamarão. The areas of Medical Devices and International Cooperation of the Agency also took part of this delegation.
Link News: portal.anvisa.gov.br